TD Cowen on United Therapeutics (UTHR): Management Sees Blockbuster Potential as Ralinepag Succeeds
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 587.50 +2.71 (0.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $584.79 | 52 Week High | $164.04 | |||
| Open | $584.92 | 52 Week Low | $97.52 | |||
| Day High | $590.98 | P/E | 107.40 | |||
| Day Low | $576.24 | EPS | $5.47 | |||
| Volume | 637,874 | |||||
